2023 Form 20-F Financial Statement

#000141057823000835 Filed on April 28, 2023

View on sec.gov

Income Statement

Concept 2023 2022 Q4 2022
Revenue $193.7M $552.4M $2.468B
YoY Change -92.15% -15.7% 3.42%
Cost Of Revenue $105.8M $230.1M $1.056B
YoY Change -89.99% -29.78% -12.1%
Gross Profit $87.94M $322.4M $1.412B
YoY Change -93.77% -1.59% 19.15%
Gross Profit Margin 45.4% 58.36% 57.21%
Selling, General & Admin $84.40M $298.9M $180.8M
YoY Change -53.32% -15.64% -87.28%
% of Gross Profit 95.98% 92.71% 12.8%
Research & Development $11.65M $28.10M $72.03M
YoY Change -83.82% -16.53% -31.52%
% of Gross Profit 13.25% 8.72% 5.1%
Depreciation & Amortization $91.68M $13.64M
YoY Change 572.4% -89.12%
% of Gross Profit 104.26% 0.97%
Operating Expenses $96.06M $326.9M $252.8M
YoY Change -62.01% -15.74% -83.73%
Operating Profit $1.895M -$4.500M $13.49M
YoY Change -85.95% -92.55% -103.65%
Interest Expense $1.000M $1.700M
YoY Change 31.41% -6.44%
% of Operating Profit 12.6%
Other Income/Expense, Net $102.0K $3.500M $11.28M
YoY Change -99.1% 27.37% 102.49%
Pretax Income $14.36M -$100.0K $106.1M
YoY Change -86.46% -99.82% -129.32%
Income Tax -$7.972M $17.60M $20.83M
% Of Pretax Income -55.51% 19.64%
Net Earnings $1.459M -$18.50M $12.36M
YoY Change -88.19% -89.86% -102.6%
Net Earnings / Revenue 0.75% -3.35% 0.5%
Basic Earnings Per Share $7.64
Diluted Earnings Per Share -$0.34 $7.23
COMMON SHARES
Basic Shares Outstanding 53.87M 54.66M
Diluted Shares Outstanding 55.33M 57.73M

Balance Sheet

Concept 2023 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $362.5M $362.5M
YoY Change -15.7% -15.7%
Cash & Equivalents $51.65M $356.2M
Short-Term Investments $6.300M $6.300M
Other Short-Term Assets $20.16M $201.2M
YoY Change -85.6% 68.47%
Inventory $7.186M
Prepaid Expenses
Receivables $68.73M $69.40M
Other Receivables $92.00K $34.50M
Total Short-Term Assets $96.79M $667.6M
YoY Change -84.37% 7.79%
LONG-TERM ASSETS
Property, Plant & Equipment $122.8M $473.3M
YoY Change -84.56% -40.49%
Goodwill $7.653M
YoY Change -85.5%
Intangibles $1.093M
YoY Change -88.97%
Long-Term Investments $19.18M $46.40M
YoY Change -58.81% -0.37%
Other Assets $48.87M $89.00M
YoY Change -58.25% -23.96%
Total Long-Term Assets $97.13M $669.9M
YoY Change -90.5% -34.48%
TOTAL ASSETS
Total Short-Term Assets $96.79M $667.6M
Total Long-Term Assets $97.13M $669.9M
Total Assets $193.9M $1.338B
YoY Change -88.19% -18.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $918.0K $6.300M
YoY Change -89.7% -29.32%
Accrued Expenses $603.5M $748.4M
YoY Change -24.89% 0.93%
Deferred Revenue
YoY Change
Short-Term Debt $52.00M $52.00M
YoY Change 73.33% 73.33%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $385.2M $2.657B
YoY Change -86.9% -9.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $645.0K $187.2M
YoY Change -99.78% -36.35%
Total Long-Term Liabilities $645.0K $187.2M
YoY Change -99.78% -36.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $385.2M $2.657B
Total Long-Term Liabilities $645.0K $187.2M
Total Liabilities $412.4M $2.837B
YoY Change -87.22% -12.04%
SHAREHOLDERS EQUITY
Retained Earnings -$353.3M
YoY Change -85.98%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$217.5M -$1.500B
YoY Change
Total Liabilities & Shareholders Equity $193.9M $1.338B
YoY Change -88.19% -18.53%

Cashflow Statement

Concept 2023 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $1.459M -$18.50M $12.36M
YoY Change -88.19% -89.86% -102.6%
Depreciation, Depletion And Amortization $91.68M $13.64M
YoY Change 572.4% -89.12%
Cash From Operating Activities -$16.75M -$3.992M
YoY Change 319.59% -146.36%
INVESTING ACTIVITIES
Capital Expenditures $38.80M
YoY Change -157.32%
Acquisitions
YoY Change
Other Investing Activities $16.10M
YoY Change -84.12%
Cash From Investing Activities $10.15M -$3.292M
YoY Change -408.23% -109.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.480M
YoY Change -37.17%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.041M -306.0K
YoY Change 1547.39% -101.32%
NET CHANGE
Cash From Operating Activities -16.75M -3.992M
Cash From Investing Activities 10.15M -3.292M
Cash From Financing Activities -5.041M -306.0K
Net Change In Cash -11.85M -7.258M
YoY Change 63.23% -111.07%
FREE CASH FLOW
Cash From Operating Activities -$16.75M -$3.992M
Capital Expenditures $38.80M
Free Cash Flow -$42.79M
YoY Change -156.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Document Type
DocumentType
20-F
CY2022 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7201000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-138000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7779000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.315
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.196
CY2021 tedu Reversal Of Valuation Allowance
ReversalOfValuationAllowance
-188000
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-36363
CY2022 dei Entity Registrant Name
EntityRegistrantName
Tarena International, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001592560
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
6/F, No. 1 Andingmenwai Street, Litchi Tower
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Chaoyang District
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Beijing
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
100011
CY2022 dei Entity Address Country
EntityAddressCountry
CN
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Firm
AuditorFirmId
5395
CY2022 dei Auditor Name
AuditorName
Marcum Asia CPAs LLP
CY2022 dei Auditor Location
AuditorLocation
Beijing China
CY2021Q4 us-gaap Cash
Cash
423766000
CY2022Q4 us-gaap Cash
Cash
356237000
CY2022Q4 us-gaap Cash
Cash
51650000
CY2021Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
6257000
CY2022Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
6277000
CY2022Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
910000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
255000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
17730000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
2571000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
48458000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
68733000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9965000
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
839000
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
698000
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
101000
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
106539000
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
15447000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
139757000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
111339000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16142000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
619332000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
667553000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
96786000
CY2021Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
123000
CY2022Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
228000
CY2022Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
33000
CY2021Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
90000
CY2022Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
182000
CY2022Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
26000
CY2021Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
683000
CY2022Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
701000
CY2022Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
102000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
299441000
CY2022Q4 us-gaap Liabilities
Liabilities
2844181000
CY2022Q4 us-gaap Liabilities
Liabilities
412367000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
122834000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17809000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9906000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7542000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1093000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
495936000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
350501000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50818000
CY2021Q4 us-gaap Goodwill
Goodwill
52782000
CY2022Q4 us-gaap Goodwill
Goodwill
52782000
CY2022Q4 us-gaap Goodwill
Goodwill
7653000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
46449000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
46183000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
6696000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
41000000
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
40127000
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
5818000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
76040000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
48867000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7085000
CY2021Q4 us-gaap Assets
Assets
1641782000
CY2022Q4 us-gaap Assets
Assets
1337500000
CY2022Q4 us-gaap Assets
Assets
193919000
CY2021Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
30000000
CY2022Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
52000000
CY2022Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
7539000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8914000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6330000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
918000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
554000
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
87000
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
13000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
239937000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
197969000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
28703000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
89000000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
108434000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
15721000
CY2021Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
2008078000
CY2022Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
1688610000
CY2022Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
244825000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
563603000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
603516000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
87502000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2940086000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2656946000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
385221000
CY2021Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
16774000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1347205000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1363845000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
197739000
CY2022Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
14051000
CY2022Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
2037000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
272575000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
168736000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24464000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4767000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4448000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
645000
CY2021Q4 us-gaap Liabilities
Liabilities
3234202000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
48699000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
49664000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-806227000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1636000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2520438000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2436918000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-353320000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1583920000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1499894000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-217464000
CY2021Q4 tedu Non Controlling Interest
NonControllingInterest
-8500000
CY2022Q4 tedu Non Controlling Interest
NonControllingInterest
-6787000
CY2022Q4 tedu Non Controlling Interest
NonControllingInterest
-984000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1641782000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1337500000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
193919000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1897883000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2386520000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2468074000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
357837000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
1066842000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
1201419000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
1056043000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
153112000
CY2020 us-gaap Gross Profit
GrossProfit
831041000
CY2021 us-gaap Gross Profit
GrossProfit
1185101000
CY2022 us-gaap Gross Profit
GrossProfit
1412031000
CY2022 us-gaap Gross Profit
GrossProfit
204725000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
906337000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
878130000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
642937000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
93217000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
630618000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
569985000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
604028000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
87576000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
100466000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
106098000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
72028000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10443000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-806380000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-369112000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
93038000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
13489000
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-199000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2335000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2700000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
391000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5201000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5572000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11283000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4849000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-518000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-954000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-361723000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
106067000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15378000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-35034000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114057000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20834000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3021000
CY2020 us-gaap Profit Loss
ProfitLoss
-771193000
CY2021 us-gaap Profit Loss
ProfitLoss
-475780000
CY2022 us-gaap Profit Loss
ProfitLoss
85233000
CY2022 us-gaap Profit Loss
ProfitLoss
12357000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4550000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1233000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1713000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
248000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-766643000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-474547000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
83520000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
12109000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-70.54
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-42.17
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.64
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-70.54
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-42.17
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.23
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.05
CY2020 us-gaap Profit Loss
ProfitLoss
-771193000
CY2021 us-gaap Profit Loss
ProfitLoss
-475780000
CY2022 us-gaap Profit Loss
ProfitLoss
85233000
CY2022 us-gaap Profit Loss
ProfitLoss
12357000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2266000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-421000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
965000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
140000
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-773459000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-476201000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
86198000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
12497000
CY2020 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-4550000
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1233000
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1713000
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
248000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-768909000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-474968000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
84485000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12249000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-403064000
CY2020 us-gaap Profit Loss
ProfitLoss
-771193000
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3354000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2266000
CY2020 tedu Comprehensive Income Net Of Tax To Noncontrolling Interest Contribution
ComprehensiveIncomeNetOfTaxToNoncontrollingInterestContribution
300000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36246000
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2646000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1139269000
CY2021 us-gaap Profit Loss
ProfitLoss
-475780000
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3947000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-421000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19103000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1592420000
CY2022 us-gaap Profit Loss
ProfitLoss
85233000
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
107000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
965000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16537000
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
17103000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1506681000
CY2020 us-gaap Profit Loss
ProfitLoss
-771193000
CY2021 us-gaap Profit Loss
ProfitLoss
-475780000
CY2022 us-gaap Profit Loss
ProfitLoss
85233000
CY2022 us-gaap Profit Loss
ProfitLoss
12357000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
177478000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
125305000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
94046000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13635000
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
170022000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
250041000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
172912000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
25070000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13900000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5773000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
37866000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5490000
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3303000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-24669000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-12788000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1854000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-42431000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
101220000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
873000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
127000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
36246000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
19103000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
16537000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
2398000
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-77000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1375000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4542000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
659000
CY2020 tedu Foreign Currency Transaction Gain Loss Before Tax1
ForeignCurrencyTransactionGainLossBeforeTax1
-4849000
CY2021 tedu Foreign Currency Transaction Gain Loss Before Tax1
ForeignCurrencyTransactionGainLossBeforeTax1
-518000
CY2022 tedu Foreign Currency Transaction Gain Loss Before Tax1
ForeignCurrencyTransactionGainLossBeforeTax1
-954000
CY2022 tedu Foreign Currency Transaction Gain Loss Before Tax1
ForeignCurrencyTransactionGainLossBeforeTax1
-138000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21339000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
35785000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5188000
CY2020 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
252000
CY2021 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
1217000
CY2022 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-186000
CY2022 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-27000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1511000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-18124000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3944000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
572000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-14549000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-13887000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-33887000
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-4913000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
821000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-156000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
975000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
141000
CY2020 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-58000
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
374000
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-468000
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-68000
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7146000
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
12183000
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
19434000
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2818000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
412228000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
26654000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-322191000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-46713000
CY2020 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2289000
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
163292000
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
37314000
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
5410000
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-128186000
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-252351000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-173284000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-25124000
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-319000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-315000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-319000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-46000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-108821000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8610000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27528000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3992000
CY2020 tedu Purchase Of Property And Equipment And Intangible Assets
PurchaseOfPropertyAndEquipmentAndIntangibleAssets
79414000
CY2021 tedu Purchase Of Property And Equipment And Intangible Assets
PurchaseOfPropertyAndEquipmentAndIntangibleAssets
67694000
CY2022 tedu Purchase Of Property And Equipment And Intangible Assets
PurchaseOfPropertyAndEquipmentAndIntangibleAssets
38768000
CY2022 tedu Purchase Of Property And Equipment And Intangible Assets
PurchaseOfPropertyAndEquipmentAndIntangibleAssets
5621000
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7909000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
85083000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
807000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
117000
CY2020 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
4000000
CY2022 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
3000000
CY2022 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
435000
CY2021 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
9500000
CY2022 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
17975000
CY2022 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
2606000
CY2020 tedu Payments To Acquire Time Deposits
PaymentsToAcquireTimeDeposits
94426000
CY2021 tedu Payments To Acquire Time Deposits
PaymentsToAcquireTimeDeposits
50129000
CY2022 tedu Payments To Acquire Time Deposits
PaymentsToAcquireTimeDeposits
120000
CY2022 tedu Payments To Acquire Time Deposits
PaymentsToAcquireTimeDeposits
17000
CY2020 tedu Proceeds From Maturity Of Deposits
ProceedsFromMaturityOfDeposits
171660000
CY2021 tedu Proceeds From Maturity Of Deposits
ProceedsFromMaturityOfDeposits
50000000
CY2020 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
8782000
CY2021 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
402000
CY2020 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
6396000
CY2021 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
7335000
CY2022 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
397000
CY2022 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
58000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-657000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
33693000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22709000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3292000
CY2020 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
10710000
CY2021 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
30000000
CY2022 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
52000000
CY2022 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
7539000
CY2020 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
300000
CY2020 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
89162000
CY2021 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
10710000
CY2022 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
30000000
CY2022 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
4350000
CY2020 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
6499000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3354000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3947000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
107000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16000
CY2022 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
7109000
CY2022 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1031000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
17103000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2480000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-68299000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23237000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2105000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-306000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-177777000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
65540000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-52342000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7590000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1376000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-67000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2288000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
332000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-179153000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
65473000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-50054000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7258000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
537701000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
358548000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
424021000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61479000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
320179000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
423766000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
356237000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51650000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
38369000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
255000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
17730000
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
2571000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
358548000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
424021000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
373967000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54221000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
615000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
654000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
527000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
76000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
4954000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
463000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1497000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
217000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9180000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7957000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4398000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
638000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
484202000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
185875000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
112966000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
16379000
CY2022 tedu Equity Method Investments Percentage Of Equity Acquired Through Options
EquityMethodInvestmentsPercentageOfEquityAcquiredThroughOptions
1
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 18pt;">(b)   Use of estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include goodwill impairment and long term investments, the allowance for credit losses of accounts receivable, amounts due from related parties, prepaid expenses and other current assets and other non-current assets, the realizability of deferred income tax assets, the accruals for other contingencies, the useful lives of property and equipment and the recoverability of the carrying amounts of property and equipment and right-of-use assets. The current economic environment has increased the degree of uncertainty inherent in those estimates and assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">The preparation of these financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, the Company evaluates its estimates based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">To allocate the transaction price for contracts with multiple deliverables and estimate the standalone selling price, the Company considers market data, including its pricing strategies for the products being evaluated and other similar products it offers, competitor pricing to the extent data is available, and costs to determine whether the estimated selling price yields an appropriate profit margin.</p>
CY2021Q4 tedu Cash Cash Equivalents And Restricted Investments
CashCashEquivalentsAndRestrictedInvestments
430401000
CY2022Q4 tedu Cash Cash Equivalents And Restricted Investments
CashCashEquivalentsAndRestrictedInvestments
380472000
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
48548000
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
68915000
CY2022 tedu Number Of Office Buildings
NumberOfOfficeBuildings
2
CY2022 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
102800000
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
11600000
CY2021 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2020Q4 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
1221729000
CY2021Q4 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
1370448000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2024852000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1702661000
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
14051000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
72028000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
297484000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
229571000
CY2022 us-gaap Advertising Expense
AdvertisingExpense
175648000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
100466000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
106098000
CY2020 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
53750000
CY2021 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
133012000
CY2022 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
133013000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
48458000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
68733000
CY2021Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
90000
CY2022Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
182000
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q4 tedu Accounts Receivable Face Amount
AccountsReceivableFaceAmount
64596000
CY2022Q4 tedu Accounts Receivable Face Amount
AccountsReceivableFaceAmount
100578000
CY2021Q4 us-gaap Deferred Discounts Finance Charges And Interest Included In Receivables
DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables
1061000
CY2022Q4 us-gaap Deferred Discounts Finance Charges And Interest Included In Receivables
DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables
1145000
CY2021Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
63535000
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
99433000
CY2021Q4 tedu Allowance For Credit Loss Accounts Receivable
AllowanceForCreditLossAccountsReceivable
14987000
CY2022Q4 tedu Allowance For Credit Loss Accounts Receivable
AllowanceForCreditLossAccountsReceivable
30518000
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
48548000
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
68915000
CY2022Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
11647000
CY2021Q4 tedu Prepaid Security Deposits
PrepaidSecurityDeposits
24518000
CY2022Q4 tedu Prepaid Security Deposits
PrepaidSecurityDeposits
29915000
CY2021Q4 tedu Prepaid Employee Personal Loans
PrepaidEmployeePersonalLoans
20584000
CY2022Q4 tedu Prepaid Employee Personal Loans
PrepaidEmployeePersonalLoans
34421000
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
18350000
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
16736000
CY2021Q4 tedu Professional Fees Current
ProfessionalFeesCurrent
18244000
CY2022Q4 tedu Professional Fees Current
ProfessionalFeesCurrent
16078000
CY2021Q4 us-gaap Prepaid Rent
PrepaidRent
15669000
CY2022Q4 us-gaap Prepaid Rent
PrepaidRent
6837000
CY2021Q4 tedu Long Term Investment Disposal Receivable Current
LongTermInvestmentDisposalReceivableCurrent
13000000
CY2021Q4 us-gaap Inventory Net
InventoryNet
5870000
CY2022Q4 us-gaap Inventory Net
InventoryNet
7186000
CY2021Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
2654000
CY2022Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
9743000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
28273000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
20163000
CY2021Q4 tedu Prepaid Expense And Other Assets Current Gross
PrepaidExpenseAndOtherAssetsCurrentGross
147162000
CY2022Q4 tedu Prepaid Expense And Other Assets Current Gross
PrepaidExpenseAndOtherAssetsCurrentGross
141079000
CY2021Q4 tedu Prepaid Expense And Other Assets Current Allownce For Credit Loss
PrepaidExpenseAndOtherAssetsCurrentAllownceForCreditLoss
7405000
CY2022Q4 tedu Prepaid Expense And Other Assets Current Allownce For Credit Loss
PrepaidExpenseAndOtherAssetsCurrentAllownceForCreditLoss
29740000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
139757000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
111339000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7405000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7405000
CY2020 tedu Provision For Doubtful Account
ProvisionForDoubtfulAccount
7405000
CY2022 tedu Provision For Doubtful Account
ProvisionForDoubtfulAccount
22335000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7405000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7405000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
29740000
CY2021Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
7414000
CY2022Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
5850000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
854035000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
668259000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
554594000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
545425000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
299441000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
122834000
CY2021 us-gaap Depreciation
Depreciation
171256000
CY2022 us-gaap Depreciation
Depreciation
121760000
CY2023 us-gaap Depreciation
Depreciation
91682000
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
29880000
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
27000000
CY2021Q4 tedu Equity Method Investment Impairment
EquityMethodInvestmentImpairment
-524000
CY2022Q4 tedu Equity Method Investment Impairment
EquityMethodInvestmentImpairment
-524000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
16569000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
19183000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
46449000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
46183000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
43498000
CY2022Q4 tedu Recharge Card Liability Current
RechargeCardLiabilityCurrent
156003000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
41276000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
35469000
CY2022Q4 tedu Accrued Compensation For Minority Shareholder Litigation
AccruedCompensationForMinorityShareholderLitigation
20894000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
18513000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
19597000
CY2021Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
18231000
CY2022Q4 us-gaap Accrued Advertising Current
AccruedAdvertisingCurrent
18696000
CY2021Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
9744000
CY2021Q4 tedu Rent And Property Management Deposits
RentAndPropertyManagementDeposits
48531000
CY2022Q4 tedu Rent And Property Management Deposits
RentAndPropertyManagementDeposits
34830000
CY2021Q4 tedu Loans Made To Employees Non Current
LoansMadeToEmployeesNonCurrent
16825000
CY2022Q4 tedu Loans Made To Employees Non Current
LoansMadeToEmployeesNonCurrent
220000
CY2021Q4 tedu Prepayments For Equipment And Lease Improvement Noncurrent
PrepaymentsForEquipmentAndLeaseImprovementNoncurrent
8443000
CY2022Q4 tedu Prepayments For Equipment And Lease Improvement Noncurrent
PrepaymentsForEquipmentAndLeaseImprovementNoncurrent
4979000
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2241000
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
8838000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
76040000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
48867000
CY2022 tedu Loans Issued To Related Party Term Of Loan
LoansIssuedToRelatedPartyTermOfLoan
P5Y
CY2021Q3 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
95000
CY2021 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
30000000
CY2022Q4 us-gaap Short Term Debt Percentage Bearing Variable Interest Rate
ShortTermDebtPercentageBearingVariableInterestRate
0.053
CY2022Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
52000000
CY2022 us-gaap Debt Instrument Term
DebtInstrumentTerm
P12M
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
5047000
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
322000
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
1508000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
201657000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
153631000
CY2021Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
147210000
CY2022Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
148245000
CY2021Q4 tedu Recharge Card Liability Current
RechargeCardLiabilityCurrent
76060000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
33484000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
563603000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
603516000
CY2020 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
4252000
CY2021 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
7070000
CY2022 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
5361000
CY2020 tedu Revenue From Contract With Customer Excluding Assessed Taxes
RevenueFromContractWithCustomerExcludingAssessedTaxes
1884875000
CY2021 tedu Revenue From Contract With Customer Excluding Assessed Taxes
RevenueFromContractWithCustomerExcludingAssessedTaxes
2378635000
CY2022 tedu Revenue From Contract With Customer Excluding Assessed Taxes
RevenueFromContractWithCustomerExcludingAssessedTaxes
2455571000
CY2020 tedu Revenue From Contract With Customer Excluding Assessed Taxes
RevenueFromContractWithCustomerExcludingAssessedTaxes
1884875000
CY2021 tedu Revenue From Contract With Customer Excluding Assessed Taxes
RevenueFromContractWithCustomerExcludingAssessedTaxes
2378635000
CY2022 tedu Revenue From Contract With Customer Excluding Assessed Taxes
RevenueFromContractWithCustomerExcludingAssessedTaxes
2455571000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2022 tedu Income Taxes Preferential Income Tax Rate Advanced And New Technology Enterprises
IncomeTaxesPreferentialIncomeTaxRateAdvancedAndNewTechnologyEnterprises
0.15
tedu Income Taxes Preferential Income Tax Rate Advanced And New Technology Enterprises
IncomeTaxesPreferentialIncomeTaxRateAdvancedAndNewTechnologyEnterprises
0.15
tedu Income Taxes Preferential Income Tax Rate Advanced And New Technology Enterprises
IncomeTaxesPreferentialIncomeTaxRateAdvancedAndNewTechnologyEnterprises
0.15
tedu Income Taxes Preferential Income Tax Rate Advanced And New Technology Enterprises
IncomeTaxesPreferentialIncomeTaxRateAdvancedAndNewTechnologyEnterprises
0.15
tedu Income Taxes Assessable Profit Tax Rate
IncomeTaxesAssessableProfitTaxRate
25
tedu Assessable Profit Before Tax
AssessableProfitBeforeTax
1000000.0
CY2021 tedu Income Taxes Assessable Profit Tax Rate
IncomeTaxesAssessableProfitTaxRate
12.5
CY2021 tedu Assessable Profit Before Tax
AssessableProfitBeforeTax
1000000.0
CY2022 tedu Income Taxes Assessable Profit Tax Rate
IncomeTaxesAssessableProfitTaxRate
12.5
CY2022 tedu Assessable Profit Before Tax
AssessableProfitBeforeTax
1000000.0
tedu Income Taxes Assessable Profit Tax Rate
IncomeTaxesAssessableProfitTaxRate
25
tedu Assessable Profit Before Tax
AssessableProfitBeforeTax
1000000.0
tedu Income Taxes Preferential Income Tax Rate Small Profit Enterprises
IncomeTaxesPreferentialIncomeTaxRateSmallProfitEnterprises
0.20
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Holidays
EffectiveIncomeTaxRateReconciliationTaxHolidays
0
CY2022Q4 us-gaap Deferred Tax Assets Investment In Subsidiaries
DeferredTaxAssetsInvestmentInSubsidiaries
293000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-806227000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-361723000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
106067000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.452
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
7397000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
12837000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
19961000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-42431000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
101220000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
873000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-35034000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114057000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20834000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.250
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.250
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.250
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.018
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.011
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.123
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.020
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.034
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.061
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.016
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.020
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.071
CY2022 tedu Tax Impact Of Investment Loss
TaxImpactOfInvestmentLoss
-0.141
CY2020 tedu Effective Income Tax Rate Reconciliation Preferential Tax Rates Percent
EffectiveIncomeTaxRateReconciliationPreferentialTaxRatesPercent
-0.112
CY2021 tedu Effective Income Tax Rate Reconciliation Preferential Tax Rates Percent
EffectiveIncomeTaxRateReconciliationPreferentialTaxRatesPercent
-0.095
CY2022 tedu Effective Income Tax Rate Reconciliation Preferential Tax Rates Percent
EffectiveIncomeTaxRateReconciliationPreferentialTaxRatesPercent
-0.474
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.029
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.055
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.024
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.052
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.418
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.043
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
11750000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
11750000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
281813000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
354806000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
30955000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
35210000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5326000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6069000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
329844000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
407835000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
288844000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
367708000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
41000000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
40127000
CY2021Q4 tedu Deferred Tax Liabilities Valuation Appreciation Of Intangible Assets
DeferredTaxLiabilitiesValuationAppreciationOfIntangibleAssets
1067000
CY2022Q4 tedu Deferred Tax Liabilities Valuation Appreciation Of Intangible Assets
DeferredTaxLiabilitiesValuationAppreciationOfIntangibleAssets
750000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1067000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
750000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
139177000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
146371000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
288844000
CY2020 tedu Valuation Allowance Deferred Tax Asset Additions
ValuationAllowanceDeferredTaxAssetAdditions
46755000
CY2021 tedu Valuation Allowance Deferred Tax Asset Additions
ValuationAllowanceDeferredTaxAssetAdditions
168163000
CY2022 tedu Valuation Allowance Deferred Tax Asset Additions
ValuationAllowanceDeferredTaxAssetAdditions
79445000
CY2020 tedu Valuation Allowance Deferred Tax Asset Reductions
ValuationAllowanceDeferredTaxAssetReductions
4643000
CY2021 tedu Valuation Allowance Deferred Tax Asset Reductions
ValuationAllowanceDeferredTaxAssetReductions
16752000
CY2022 tedu Valuation Allowance Deferred Tax Asset Reductions
ValuationAllowanceDeferredTaxAssetReductions
20162000
CY2022 tedu Reversal Of Valuation Allowance
ReversalOfValuationAllowance
-11297000
CY2020 tedu Change Of Deferred Tax Asset Rate
ChangeOfDeferredTaxAssetRate
30671000
CY2021 tedu Change Of Deferred Tax Asset Rate
ChangeOfDeferredTaxAssetRate
8038000
CY2022 tedu Change Of Deferred Tax Asset Rate
ChangeOfDeferredTaxAssetRate
-31171000
CY2020 tedu Change Of Deferred Tax Asset Decrease Related To Subsidiary Disposals And Expiration
ChangeOfDeferredTaxAssetDecreaseRelatedToSubsidiaryDisposalsAndExpiration
4247000
CY2021 tedu Change Of Deferred Tax Asset Decrease Related To Subsidiary Disposals And Expiration
ChangeOfDeferredTaxAssetDecreaseRelatedToSubsidiaryDisposalsAndExpiration
712000
CY2022 tedu Change Of Deferred Tax Asset Decrease Related To Subsidiary Disposals And Expiration
ChangeOfDeferredTaxAssetDecreaseRelatedToSubsidiaryDisposalsAndExpiration
293000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
146371000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
288844000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
367708000
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2830342000
CY2021Q4 us-gaap Due From Related Parties
DueFromRelatedParties
839000
CY2022Q4 us-gaap Due From Related Parties
DueFromRelatedParties
698000
CY2022Q4 tedu Statutory Reserves Percentage Of Appropriation From Net Profit
StatutoryReservesPercentageOfAppropriationFromNetProfit
0.10
CY2022Q4 tedu Statutory Reserves Balance As Percentage To Capital
StatutoryReservesBalanceAsPercentageToCapital
0.50
CY2022Q4 tedu Statutory Reserves For Private Schools Requiring Reasonable Returns Percentage Of Appropriation From Net Profit
StatutoryReservesForPrivateSchoolsRequiringReasonableReturnsPercentageOfAppropriationFromNetProfit
0.25
CY2022Q4 tedu Statutory Reserves For Private Schools Not Requiring Reasonable Returns Percentage Of Expected Annual Increase In Net Assets
StatutoryReservesForPrivateSchoolsNotRequiringReasonableReturnsPercentageOfExpectedAnnualIncreaseInNetAssets
0.25
CY2020 tedu Statutory Accounting Practices Statutory Appropriations
StatutoryAccountingPracticesStatutoryAppropriations
5307000
CY2021 tedu Statutory Accounting Practices Statutory Appropriations
StatutoryAccountingPracticesStatutoryAppropriations
16736000
CY2022 tedu Statutory Accounting Practices Statutory Appropriations
StatutoryAccountingPracticesStatutoryAppropriations
19037000
CY2021Q4 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
175564000
CY2022Q4 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
194601000
CY2021Q4 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
1523198000
CY2022Q4 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
1558879000
CY2020 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1236146
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
879000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1166980
CY2022 tedu Short Term Lease Rental Expense
ShortTermLeaseRentalExpense
20379000
CY2022 tedu Income Tax Benefit From Share Based Compensation
IncomeTaxBenefitFromShareBasedCompensation
0
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
170022000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
250043000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2740020
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.67
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1976000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1166980
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.01
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
398000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.01
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
152365
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.44
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3356635
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.10
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M20D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2994000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4821350
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.29
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y8M12D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
4378000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2408105
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.65
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y11M15D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2118000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
26301000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6261000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2543000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
194742000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.52
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.82
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.92
CY2020 tedu Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateGrantDateFairValue
3115000
CY2021 tedu Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateGrantDateFairValue
720000
CY2022 tedu Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Aggregate Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAggregateGrantDateFairValue
1079000
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
6721000
CY2022 tedu Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognitionStockOptions
P4Y4M17D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
159385
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
7.11
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
387170
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.47
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
185685
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.62
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
215950
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.89
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
144920
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.38
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
4382000
CY2022 tedu Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognitionShareBasedAwardsOtherThanOptions
P0Y8M15D
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
9013000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
5930000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
3358000
CY2021 tedu Short Term Lease Rental Expense
ShortTermLeaseRentalExpense
35707000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-766643000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-474547000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
83520000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54341213
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56260925
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54657222
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3073450
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54341213
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56260925
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57730672
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-70.54
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-42.17
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.64
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-70.54
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-42.17
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.23
CY2020 tedu Short Term Lease Rental Expense
ShortTermLeaseRentalExpense
114723000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
244491000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
228857000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
173352000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
484202000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
185875000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
112966000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M3D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y5M15D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0560
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0561
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
211376000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
104068000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
50572000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
18296000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4499000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1021000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
389832000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
23127000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
366705000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
197969000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
168736000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
284745000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
285750000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
215121000
CY2020 us-gaap Sublease Income
SubleaseIncome
971000
CY2021 us-gaap Sublease Income
SubleaseIncome
583000
CY2022 us-gaap Sublease Income
SubleaseIncome
330000
CY2022 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">17   COMMITMENTS AND CONTINGENCIES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 18pt;">The Company and certain of its current and former officers and directors have been named as defendants in a putative securities class action captioned Yili Qiu v. Tarena International, Inc. et al., (Case No. 1:21-cv-03502) filed on June 22, 2021 in the U.S. District Court for the Eastern District of New York. The complaint asserts that defendants made false or misleading statements in certain SEC filings between August 16, 2016 and November 1, 2019 related to the Company’s business and operating results in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. On September 1, 2021, the court entered an order appointing lead plaintiff in this action. On September 14, 2021, the parties filed a joint status report and proposed scheduling stipulation, pursuant to which, the lead plaintiff filed an amended complaint on November 1, 2021. On December 16, 2021, the Company filed its pre-motion letter and the plaintiffs filed their opposition on December 23, 2021. On January 18, 2022, the Company moved to dismiss the complaint. On April 4, 2022, lead plaintiff served its opposition to the motion. Briefing was completed on May 19, 2022. While the motion to dismiss was pending, Plaintiff and the Company reached an agreement in principle to settle all claims. On July 13, 2022, Plaintiff filed a letter informing the court of the settlement in principle. On August 31, 2022, the parties filed a motion for preliminary approval of the proposed settlement agreement. Preliminary approval hearing took place on November 8, 2022, and the Court reserved judgement on the motion pending submission of additional information. In December 2022, the parties submitted revised settlement materials to the Court. The Court decision on the revised settlement papers is pending. An estimated loss amounting to $3.0 million from this litigation was accrued by a charge to general and administrative expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 18pt;">There will have no material adverse effect on the Company’s financial position, results of operations or liquidity.</p>
CY2022 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
3000000.0
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2468074000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
1056043000
CY2022 us-gaap Gross Profit
GrossProfit
1412031000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2386520000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
1201419000
CY2021 us-gaap Gross Profit
GrossProfit
1185101000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1897883000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
1066842000
CY2020 us-gaap Gross Profit
GrossProfit
831041000

Files In Submission

Name View Source Status
tedu-20221231x20f_htm.xml Edgar Link completed
0001410578-23-000835-index-headers.html Edgar Link pending
0001410578-23-000835-index.html Edgar Link pending
0001410578-23-000835.txt Edgar Link pending
0001410578-23-000835-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tedu-20221231.xsd Edgar Link pending
tedu-20221231x20f.htm Edgar Link pending
tedu-20221231x20f007.jpg Edgar Link pending
tedu-20221231xex12d1.htm Edgar Link pending
tedu-20221231xex12d2.htm Edgar Link pending
tedu-20221231xex13d1.htm Edgar Link pending
tedu-20221231xex13d2.htm Edgar Link pending
tedu-20221231xex15d1.htm Edgar Link pending
tedu-20221231xex15d2.htm Edgar Link pending
tedu-20221231xex15d2001.jpg Edgar Link pending
tedu-20221231xex15d2002.jpg Edgar Link pending
tedu-20221231xex15d2003.jpg Edgar Link pending
tedu-20221231xex15d3.htm Edgar Link pending
tedu-20221231xex15d3001.jpg Edgar Link pending
tedu-20221231xex4d17.htm Edgar Link pending
tedu-20221231xex4d18.htm Edgar Link pending
tedu-20221231xex4d19.htm Edgar Link pending
tedu-20221231xex4d20.htm Edgar Link pending
tedu-20221231xex4d21.htm Edgar Link pending
tedu-20221231xex4d22.htm Edgar Link pending
tedu-20221231xex4d23.htm Edgar Link pending
tedu-20221231xex4d24.htm Edgar Link pending
tedu-20221231xex4d25.htm Edgar Link pending
tedu-20221231xex4d26.htm Edgar Link pending
tedu-20221231xex4d27.htm Edgar Link pending
tedu-20221231xex4d27001.jpg Edgar Link pending
tedu-20221231xex4d28.htm Edgar Link pending
tedu-20221231xex8d1.htm Edgar Link pending
tedu-20221231_cal.xml Edgar Link unprocessable
tedu-20221231_def.xml Edgar Link unprocessable
tedu-20221231_lab.xml Edgar Link unprocessable
tedu-20221231_pre.xml Edgar Link unprocessable